EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES

Ugo Testa, Germana Castelli, Elvira Pelosi, Eugenio Galli, Patrizia Chiusolo

Mediterranean Journal of Hematology and Infectious Diseases · 30.04.2025 · 17 (1) · e2025039

DOI: 10.4084/mjhid.2025.039 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mediterranean Journal of Hematology and Infectious Diseases, online erschienen am 30.04.2025. Verfasst von Ugo Testa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Istituto Superiore di Sanità, ROME, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor (CAR) T-cells therapy has improved the outcomes of patients with relapsed/refractory B-cell lymphomas, B-cell acute lymphoblastic leukemia and multiple myeloma. However, CAR-T cell therapy is also associated with distinct toxicities that contribute to morbidity and mortality. A large number of studies now define the different toxicities associated with CAR-T cell therapy and have, in part, clarified their mechanisms. In particular, cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) are the two main acute toxicity events that occur after CAR-T cell infusion. Other CAR-T-related toxicities occur later after CAR-T cell infusion and include B-cell aplasia, hypogammaglobulinemia, infections and cytopenia. Infections represent the main cause of non-relapse death observed in patients undergoing CAR-T cell therapy. Second primary malignancies are rare and are mainly represented by myeloid malignancies.

Schlagwörter

Stichwörter der Autor:innen

DiagnosisHeparin-binding proteinInfectious diseaseMeta-analysisMortalityOrgan failurePrognosisSepsisSystematic review

Autor:innen und Institutionen

  • Department of Oncology, Istituto Superiore di Sanità, ROME, Italy.
  • Hematology Department, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.

Zitieren

APA

Testa, U., Castelli, G., Pelosi, E., Galli, E., & Chiusolo, P. (2025). TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES. Mediterranean Journal of Hematology and Infectious Diseases, 17(1), e2025039. https://doi.org/10.4084/mjhid.2025.039

Vancouver

Testa U, Castelli G, Pelosi E, Galli E, Chiusolo P. TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES. Mediterranean Journal of Hematology and Infectious Diseases. 2025;17(1):e2025039. doi:10.4084/mjhid.2025.039

BibTeX
@article{Testa2025,
  author = {Testa, Ugo and Castelli, Germana and Pelosi, Elvira and Galli, Eugenio and Chiusolo, Patrizia},
  title = {TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES},
  journal = {Mediterranean Journal of Hematology and Infectious Diseases},
  year = {2025},
  volume = {17},
  number = {1},
  pages = {e2025039},
  doi = {10.4084/mjhid.2025.039}
}
Kostenlos starten →